Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Mirxes Holding Company Limited ( (HK:2629) ) is now available.
Mirxes Holding Company Limited reported a 9.4% increase in revenue for the first half of 2025, reaching $10.5 million, with significant growth in its early detection and precision multi-omics segment. Despite a reduction in losses compared to the previous year, the company still faced a loss of $28.4 million attributable to equity shareholders, highlighting ongoing financial challenges.
More about Mirxes Holding Company Limited
Mirxes Holding Company Limited operates in the biotechnology industry, focusing on early detection and precision multi-omics. The company is involved in developing innovative solutions for health diagnostics and aims to advance precision medicine.
Average Trading Volume: 965,873
Current Market Cap: HK$12.06B
For a thorough assessment of 2629 stock, go to TipRanks’ Stock Analysis page.